Geneva, March 23 -- International Clinical Trials Registry received information related to the study (NCT07452380) titled 'The Efficacy of Specific Immunotherapy Guided by Component-Resolved Diagnosis for Dust Mite Allergens in Chinese Pediatric Patients With Rhinitis and/or Asthma' on March 1.

Study Type: Observational [Patient Registry]

Primary Sponsor: The Children's Hospital of Zhejiang University School of Medicine

Condition: Allergic Rhinitis Due to House Dust Mite

Recruitment Status: Recruiting

Date of First Enrollment: November 1, 2025

Target Sample Size: 1000

Countries of Recruitment: China

To know more, visit https://clinicaltrials.gov/study/NCT07452380

Disclaimer: Curated by HT Syndication....